Skip to main content

Table 1 Infections sites in 97 children receiving ciprofloxacin

From: Current ciprofloxacin usage in children hospitalized in a referral hospital in Paris

  Community-acquired infection Healthcare-associated infection Nosocomial infection
Infection site    
Broncho-pulmonary n (%) 5 (45.4) 17 (70.8) 24 (38.6)
Urinary tract n (%) 2 (18.2) 2 (8.3) 4 (6.5)
Bloodstream/catheter infection n (%) 0 (0) 0 (0) 2(3.2) /4 (6.5)
Infection of operative site n (%) 0 (0) 0 (0) 5 (8.2)
Bone or joint n (%) 2 (18.2) 0 (0) 2 (3.2)
Intra-abdominal n (%) 1 (9.1) 0 (0) 6 (9.7)
Mediastinal$ n (%) 0 (0) 0 (0) 3 (4.8)
Cerebral n (%) 1 (9.1) 1 (4.2) 2 (3.2)
Endocarditis n (%) 0 (0) 0 (0) 2 (3.2)
Others n (%) 0 (0) 4£ (16.7) 8§ (12.9)
Total n (%) 11 (100) 24 (100) 62 (100)
  1. £: 2 BCGitis and ocular infection and cutaneous infection each.
  2. §: Fever in 8 immunocompromised children among whom 4 with current neutropenia.
  3. Among 98 children who received ciprofloxacin, one received it as prophylaxis during orthopedic surgery (not shown in Table 1).
  4. $: Mediastinal infection means mediastinitis after cardiac or thoracic surgery.